This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

EDMOND EDELSON, M.D.; AARON H. HASKIN, M.D.; William B. Ignatoff, D.S.C.; Edith Titsworth, B.S.

AMA Arch Derm Syphilol. 1952;66(2):244-250.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WE HAVE recently reported our experiences with a new antifungal agent, 2-dimethylamino-6-(beta-diethylaminoethoxy) benzothiazole (asterol®) dihydrochloride, in tinea capitis of the anthropophilic type.¹ The results of treatment in the 72 patients presented were so gratifying, even in the children whose parents contributed little cooperation, that we have since adopted the use of asterol® dihydrochloride as a routine measure in patients with ringworm of the scalp.

When Stritzler and his associates² reported their encouraging results with asterol® dihydrochloride in tinea of the glabrous skin and the nails, we decided to extend the evaluation of the new drug to patients with superficial fungous infections other than tinea capitis.

At this writing, we have collected adequate data to report our observations on asterol® dihydrochloride treatment in another group of patients with ringworm of the scalp, in a group with moniliasis, and in one with tinea . . . [Full Text PDF of this Article]

Author Affiliations
NEWARK, N. J.

From the Department of Dermatology and Syphilology, Newark Board of Health Clinics.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?